黄芪或其成分治疗急性胰腺炎的动物实验Meta分析

doi:10.12300/j.issn.1674-5817.2025.026

实验动物与比较医学 ›› 2025, Vol. 45 ›› Issue (5): 561-573.DOI: 10.12300/j.issn.1674-5817.2025.026

• 实验动物与中医药学专题 • 上一篇下一篇

黄芪或其成分治疗急性胰腺炎的动物实验Meta分析

曹星新¹, 李艾亦², 侯婧涵¹, 李明学¹, 李艳艳¹, 靳玮华¹, 杨凤梅¹, 段素琴¹, 和占龙¹()()

^1.中国医学科学院/北京协和医学院医学生物学研究所, 昆明 650018
^2.云南大学生命科学学院, 昆明 650091

收稿日期:2025-02-25 修回日期:2025-04-07 出版日期:2025-10-25 发布日期:2025-10-23
通讯作者:
和占龙（1972—），男，博士，研究员，研究方向：疾病动物模型及药物评价。E-mail：hzl@imbcams.com.cn。ORCID：0000-0001-5379-2521
作者简介:曹星新（2001—），男，硕士研究生，研究方向：疾病动物模型及药理学。E-mail：s2024018001@student.pumc.edu.cn
李艾亦（2000—），女，硕士研究生，研究方向：疾病动物模型。E-mail：15398487968@163.com
基金资助:
国家重点研发计划“大动物微生物与寄生虫质量检测关键技术研究”(2024YFF0728801);云南省基础研究专项-面上项目“小胶质细胞线粒体自噬调控NLRP3炎症小体活化对肠道病毒性脑炎的影响及机制研究”(202401CF070048)

Meta-Analysis of Animal Experiments on Astragali Radix or Its Ingredients for Acute Pancreatitis

CAO Xingxin¹, LI Aiyi², HOU Jinghan¹, LI Mingxue¹, LI Yanyan¹, JIN Weihua¹, YANG Fengmei¹, DUAN Suqin¹, HE Zhanlong¹()()

^1.Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming 650018, China
^2.College of Life Sciences, Yunnan university, Kunming 650091, China

Received:2025-02-25 Revised:2025-04-07 Published:2025-10-25 Online:2025-10-23
Contact: HE Zhanlong (ORCID: 0000-0001-5379-2521), E-mail: hzl@imbcams.com.cn

摘要/Abstract

摘要：

目的基于系统综述和荟萃分析优先报告条目（Preferred Reporting Items for Systematic reviews and Meta-Analyses，PRISMA）指南，利用Meta分析（Meta-analysis）对文献报告中利用动物实验研究黄芪（纯黄芪制剂）或其成分治疗急性胰腺炎（acute pancreatitis，AP）的药理药效结果进行定量合并，以获得精准可靠的综合效应结论。方法检索中国知网（China National Knowledge Infrastructure，CNKI）、维普中文科技期刊数据库（VIP Database for Chinese Technical Periodicals，VIP）、万方数据知识服务平台（Wanfang Data Knowledge Service Platform）、中国生物医学文献数据库（China Biomedical Literature Database，CBMdisc）、PubMed以及 Web of Science（WOS）数据库中从建库初始到2025年3月关于黄芪（纯黄芪制剂）或其成分治疗AP的动物实验相关文献。使用SYRCLE工具对纳入文献进行偏倚风险评估；对于各研究间的异质性评估遵循Cochrane手册，采用Cochrane's Q检验和I²统计量进行评价；采用留一法进行敏感性分析，并使用Egger's test检验检测发表偏倚风险。结果本文共检索得到297篇文献，经筛选及评价后，最终纳入19项动物实验进行Meta分析。这19篇文献涵盖了SD大鼠，以及C57BL/6小鼠、BALB/c小鼠和昆明小鼠3个品种的小鼠，SYRCLE评分为3～4分；敏感性分析结果显示未发现有能显著影响异质性指标的研究；Egger's test检验结果为P<0.05，显示研究间存在一定的发表偏倚；Cochrane's Q检验和I²统计量显示研究间异质性较大。19项动物实验相关文献的Meta分析结果显示，纯黄芪制剂（黄芪注射液）能降低AP特异性指标血清淀粉酶（serum amylase，AMY）的水平；黄芪成分可使AMY与脂肪酶（lipase，LPS）的水平降低。黄芪注射液或黄芪成分可使血清中肿瘤坏死因子（tumor necrosis factor，TNF）-α、白细胞介素（interleukin，IL）-6、IL-1β的水平降低，使IL-10的水平升高；并使血清中超氧化物歧化酶（superoxide dismutase，SOD）与谷胱甘肽过氧化物酶（glutathione peroxidase，GSH-Px）的水平升高，使丙二醛（malondialdehyde，MDA）的水平降低。黄芪注射液或黄芪成分的高剂量组相较低剂量组更能降低AMY、TNF-α和IL-6的水平，同时升高SOD的水平，但未证明剂量对MDA水平的影响。结论动物实验结果的循证学分析显示，在SD大鼠、C57BL/6小鼠、BALB/c小鼠、昆明小鼠等多种动物模型中，黄芪注射液或黄芪成分能有效降低AP特异性指标（AMY、LPS）的表达或分泌水平，其机制可能与部分炎症介质有关，包括降低TNF-α、IL-6和IL-1β的水平，升高IL-10的水平；同时也可能干预氧化/抗氧化平衡过程，如升高SOD和GSH-Px的水平，降低MDA的水平；除MDA外，黄芪注射液或黄芪成分对于降低AMY、TNF-α和IL-6水平以及升高SOD水平呈现剂量相关性。但由于现有研究中存在异质性较高、发表偏倚风险、动物模型与人类疾病之间的种属差异等问题，未来仍需进一步开展高质量的临床试验或动物实验研究。

关键词: 黄芪, 急性胰腺炎, 动物实验, Meta分析, 大鼠, 小鼠

Abstract:

Objective Based on the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines, to obtain precise and reliable comprehensive effect conclusions by quantitatively combining pharmacodynamic results from animal experiments investigating Astragali Radix (single-entity Astragali Radix preparation) or its ingredients for treatment of acute pancreatitis (AP) in literature reports through meta-analysis. Methods Databases including China National Knowledge Infrastructure (CNKI), VIP Database for Chinese Technical Periodicals (VIP), Wanfang Data Knowledge Service Platform, China Biomedical Literature Database (CBMdisc), PubMed, and Web of Science (WOS) were searched from inception to March 2025 for animal studies related to Astragali Radix (single-entity Astragali Radix preparation) or its ingredients for AP treatment. Risk of bias for included studies was assessed with SYRCLE tool. Heterogeneity among studies was evaluated according to Cochrane Handbook using Cochrane's Q test and I2 statistic. Sensitivity analysis was performed using the leave-one-out method, and publication bias risk was detected using Egger's test. Results A total of 297 articles were retrieved, and after screening and evaluation, 19 animal studies were finally included for meta-analysis. These 19 publications cover SD rats, as well as three breeds of mice: C57BL/6 mice, BALB/c mice, and Kunming mice. SYRCLE scores ranged from 3 to 4. The results of the sensitivity analysis showed that no study significantly affected the heterogeneity index. The results of Egger's test showed a significant publication bias with P<0.05. Cochrane's Q test and I2 statistic indicated substantial heterogeneity among studies. Meta-analysis results of 19 animal studies showed that single-entity Astragali Radix preparation (Astragali Radix injection) could reduce serum amylase (AMY) levels, an AP-specific indicator. The Astragali Radix ingredients could decrease both AMY and lipase (LPS) levels. Astragali Radix injection or its ingredients could reduce serum levels of tumor necrosis factor-α (TNF-α), interleukin (IL) -6, and IL-1β, while increasing IL-10 levels; could increase serum levels of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), and decrease malondialdehyde (MDA) levels. High-dose groups of Astragali Radix injection or Astragali Radix ingredients were more effective than low-dose groups in reducing AMY, TNF-α, and IL-6 levels and increasing SOD levels, but dosage effect on MDA levels was not demonstrated. Conclusion Evidence-based analysis of animal experiment results shows that in various animal models including SD rats, C57BL/6 mice, BALB/c mice, and Kunming mice, Astragali Radix injection or its ingredients can effectively reduce expression or secretion levels of AP-specific indicators (AMY and LPS). The mechanisms may be related to some inflammatory mediators, including reducing TNF-α, IL-6, and IL-1β levels and increasing IL-10 levels; They may also intervene in oxidative/antioxidative equilibrium, such as increasing SOD and GSH-Px levels and reducing MDA levels. Except for MDA, dose–response relationships are shown for reducing AMY, TNF-α, and IL-6 levels and increasing SOD levels with Astragali Radix injection or its ingredients. However, due to high heterogeneity, potential publication bias risk, and species differences between animal models and human diseases in existing studies, further high-quality clinical trials or animal experiments are still needed in the future.

Key words: Astragali Radix, Acute Pancreatitis, Animal experiment, Meta-analysis, Rat, Mouse

中图分类号:

R576

曹星新,李艾亦,侯婧涵,等. 黄芪或其成分治疗急性胰腺炎的动物实验Meta分析[J]. 实验动物与比较医学, 2025, 45(5): 561-573. DOI: 10.12300/j.issn.1674-5817.2025.026.

CAO Xingxin,LI Aiyi,HOU Jinghan,et al. Meta-Analysis of Animal Experiments on Astragali Radix or Its Ingredients for Acute Pancreatitis[J]. Laboratory Animal and Comparative Medicine, 2025, 45(5): 561-573. DOI: 10.12300/j.issn.1674-5817.2025.026.

图/表 7

参考文献 45

[1]	MEDEROS M A, REBER H A, GIRGIS M D. Acute pancreatitis: a review[J]. JAMA, 2021, 325(4):382-390. DOI:10.1001/jama.2020.20317 .
[2]	SCHEPERS N J, BAKKER O J, BESSELINK M G, et al. Impact of characteristics of organ failure and infected necrosis on mortality in necrotising pancreatitis[J]. Gut, 2019, 68(6):1044-1051. DOI:10.1136/gutjnl-2017-314657 .
[3]	HAN K, CHEN S M, SONG Y, et al. Burden of pancreatitis and associated risk factors in China, 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. Chin Med J (Engl), 2022, 135(11):1340-1347. DOI:10.1097/CM9.0000000000002164 .
[4]	GARDNER T B. Acute pancreatitis[J]. Ann Intern Med, 2021, 174(2): ITC17-ITC32. DOI:10.7326/aitc202102160 .
[5]	李芝萍, 汪娅君, 张菊萍, 等. 通腑逐瘀方联合常规西药治疗腑实热结证急性胰腺炎临床研究[J]. 新中医, 2024, 56(10):81-85. DOI: 10.13457/j.cnki.jncm.2024.10.016 .
	LI Z P, WANG Y J, ZHANG J P, et al. Clinical study on Tongfu Zhuyu decoction combined with conventional western medicine for acute pancreatitis with syndrome of bowel excess and heat bind[J]. New Chin Med, 2024, 56(10):81-85. DOI: 10.13457/j.cnki.jncm.2024.10.016 .
[6]	BOXHOORN L, VOERMANS R P, BOUWENSE S A, et al. Acute pancreatitis[J]. Lancet, 2020, 396(10252):726-734. DOI:10.1016/s0140-6736(20)31310-6 .
[7]	WANG P P, WANG Z, ZHANG Z P, et al. A review of the botany, phytochemistry, traditional uses, pharmacology, toxicology, and quality control of the Astragalus memeranaceus[J]. Front Pharmacol, 2023, 14:1242318. DOI:10.3389/fphar.2023.1242318 .
[8]	张琪, 张会芳, 李兆洋, 等. 黄芪注射液对急性胰腺炎患者氧化应激状态及肠黏膜屏障功能的影响[J]. 吉林中医药, 2021, 41(12):1616-1619. DOI: 10.13463/j.cnki.jlzyy.2021.12.021 .
	ZHANG Q, ZHANG H F, LI Z Y, et al. Effects of Huangqi Injection on the oxidative stress and intestinal mucosal barrier function in patients with acute pancreatitis[J]. Jilin J Chin Med, 2021, 41(12):1616-1619. DOI: 10.13463/j.cnki.jlzyy.2021.12.021 .
[9]	王嫄嫄, 郑洋, 周哲, 等. 黄芪注射液对急性胰腺炎肠道屏障功能和微炎性反应状态的影响[J]. 世界中医药, 2018, 13(4):818-821. DOI: 10.3969/j.issn.1673-7202.2018.04.008 .
	WANG Y Y, ZHENG Y, ZHOU Z, et al. Clinical study on Huangqi injection on intestinal barrier function and micro inflammatory state in patients with acute pancreatitis[J]. World Chin Med, 2018, 13(4):818-821. DOI: 10.3969/j.issn.1673-7202.2018.04.008 .
[10]	AL-MASAWA M E, ALSHAWSH M A, NG C Y, et al. Efficacy and safety of small extracellular vesicle interventions in wound healing and skin regeneration: a systematic review and meta-analysis of animal studies[J]. Theranostics, 2022, 12(15):6455-6508. DOI:10.7150/thno.73436 .
[11]	LIU D S, SONG D X, NING W H, et al. Efficacy and safety of prophylaxis for venous thromboembolism in brain neoplasm patients undergoing neurosurgery: a systematic review and Bayesian network meta-analysis[J]. J Thromb Thrombolysis, 2023, 55(4):710-720. DOI:10.1007/s11239-023-02780-3 .
[12]	孙海燕, 黄民, 关溯. 黄芪总苷对实验性急性胰腺炎的保护作用[J]. 时珍国医国药, 2006, 17(10):1980-1981. DOI: 10.3969/j.issn.1008-0805.2006.10.044 .
	SUN H Y, HUANG M, GUAN S. Effects of astragalosides on experimental acute pancreatitis[J]. Lishizhen Med Mater Med Res, 2006(10):1980-1981. DOI: 10.3969/j.issn.1008-0805.2006.10.044 .
[13]	傅强, 崔乃强, 邵伟, 等. 急性出血坏死性胰腺炎小鼠辅助性T细胞亚群1/2的变化规律及中药干预作用研究[J]. 中国中西医结合急救杂志, 2006, 13(4):214-217. DOI: 10.3321/j.issn: 1008-9691.2006.04.006 .
	FU Q, CUI N Q, SHAO W, et al. Study on regularity of changes of helper T cell subgroup Th1/Th2 and interference effect of traditional Chinese medicine in mice with acute hemorrhage necrotizing pancreatitis[J]. Chin J Integr Tradit West Med Intensive Crit Care, 2006, 13(4):214-217. DOI: 10.3321/j.issn: 1008-9691.2006.04.006 .
[14]	郭文学. 重症急性胰腺炎时MDA、SOD与肝脏微循环变化及黄芪干预的实验研究[D]. 石家庄: 河北医科大学, 2008. DOI: 10.7666/d.y1353969 .
	GUO W X. Severe acute pancreatitis MDA, SOD and liver microcirculation changes and the experimental intervention study of Astragalus[D]. Shijiazhaung: Hebei Medical University, 2008. DOI: 10.7666/d.y1353969 .
[15]	朱渊红, 王真, 蔡宛如. 黄芪注射液对SAP肺损伤大鼠的实验研究[J]. 中华中医药学刊, 2009, 27(12):2608-2609. DOI: 10.13193/j.archtcm.2009.12.146.zhuyh.041 .
	ZHU Y H, WANG Z, CAI W R. The experimental study on Astragalus to rats with lung injury associated with severe acute pancreatitis[J]. Chin Arch Tradit Chin Med, 2009, 27(12):2608-2609. DOI: 10.13193/j.archtcm.2009.12.146.zhuyh.041 .
[16]	朱渊红, 王新华, 陈芝芸. 黄芪注射液对SAP肺损伤大鼠SOD、MDA及肺组织bcl-2、bax蛋白表达的影响[J]. 中国中医药科技, 2012, 19(5):416-417, 441. DOI: 10.3969/j.issn.1005-7072.2012.05.022 .
	ZHU Y H, WANG X H, CHEN Z Y. Effects of Astragalus injection on SOD, MDA and the expression of bcl-2 and bax protein in lung tissue of rats with SAP lung injury[J]. Chin J Tradit Med Sci Technol, 2012, 19(5):416-417, 441. DOI: 10.3969/j.issn.1005-7072.2012.05.022 .
[17]	邱雷, 史建华, 殷国建, 等. 黄芪甲苷对实验性大鼠重症急性胰腺炎的治疗作用[J]. 上海医学, 2014, 37(3):227-230, 178. DOI: CNKI:SUN:SHYX.0.2014-03-020 .
	QIU L, SHI J H, YIN G J, et al. Therapeutic effects of astragaloside Ⅳ on severe acute pancreatitis in rats[J]. Shanghai Med J, 2014, 37(3):227-230, 178. DOI: CNKI:SUN:SHYX.0.2014-03-020 .[17]
[18]	王少言, 初巍巍, 霍阳, 等. 黄芪注射液对重症急性胰腺炎大鼠外周血清氧化相关物质的影响[J]. 解放军医药杂志, 2014, 26(12):5- 7. DOI: 10.3969/j.issn.2095-140X.2014.12.002 .
	WANG S Y, CHU W W, HUO Y, et al. Effect of Huangqi injection on oxidative relevant materials of peripheral serum in rats with severe acute pancreatitis[J]. Med Pharm J Chin People's Liberation Army, 2014, 26(12):5-7. DOI: 10.3969/j.issn.2095-140X.2014.12.002 .
[19]	QIU L, YIN G J, CHENG L, et al. Astragaloside Ⅳ ameliorates acute pancreatitis in rats by inhibiting the activation of nuclear factor-κB[J]. Int J Mol Med, 2015, 35(3):625-636. DOI:10.3892/ijmm.2015.2070 .
[20]	王秉钧, 王先坤, 晏波, 等. 黄芪多糖对大鼠重症急性胰腺炎的作用及机制[J]. 中国医院药学杂志, 2016, 36(16):1366-1368. DOI: 10.13286/j.cnki.chinhosppharmacyj.2016.16.08 .
	WANG B J, WANG X K, YAN B, et al. Effects of Astragalus polysaccharides on rats with severe acute pancreatitis and underlying mechanisms[J]. Chin J Hosp Pharm, 2016, 36(16):1366-1368. DOI: 10.13286/j.cnki.chinhosppharmacyj.2016.16.08 .
[21]	郑洋, 于晶晶, 杜鹃, 等. 黄芪注射液对急性胰腺炎大鼠肠道屏障功能的影响[J]. 中国临床研究, 2016, 29(12):1614-1617. DOI: 10.13429/j.cnki.cjcr.2016.12.006 .
	ZHENG Y, YU J J, DU J, et al. Effects of Astragalus injection on intestinal barrier functions in rats with acute pancreatitis[J]. Chin J Clin Res, 2016, 29(12):1614-1617. DOI: 10.13429/j.cnki.cjcr.2016.12.006 .
[22]	邓蓓蓓. 黄芪多糖对重症急性胰腺炎大鼠肠黏膜屏障损伤的保护作用[D]. 长春: 吉林大学, 2017. DOI: CNKI:CDMD:2.1017.148739 .
	ZHENG B B. Protection of astragalus polysacharin on intestinal barrier dysfunction in rats with severe acute pancreatitis[D]. Changchun: Jilin University, 2017. DOI: CNKI:CDMD:2.1017.148739 .
[23]	MA R, YUAN F, WANG S X, et al. Calycosin alleviates cerulein-induced acute pancreatitis by inhibiting the inflammatory response and oxidative stress via the p38 MAPK and NF-κB signal pathways in mice[J]. Biomed Pharmacother, 2018, 105:599-605. DOI:10.1016/j.biopha.2018.05.080 .
[24]	吴爱祥. 黄芪甲苷对重症急性胰腺炎小鼠胰腺的影响[J]. 中国临床药理学杂志, 2019, 35(18):2065-2067. DOI: 10.13699/j.cnki.1001-6821.2019.18.028 .
	WU A X. Effects of Astragalus glycoside in severe acute pancreatitis mice[J]. Chin J Clin Pharmacol, 2019, 35(18):2065-2067. DOI: 10.13699/j.cnki.1001-6821.2019.18.028 .
[25]	ZHU C J, YANG W G, LI D J, et al. Calycosin attenuates severe acute pancreatitis-associated acute lung injury by curtailing high mobility group box 1 - induced inflammation[J]. World J Gastroenterol, 2021, 27(44):7669-7686. DOI:10.3748/wjg.v27.i44.7669 .
[26]	金玲玲, 汤斌斌, 周晶晶, 等. 黄芪总皂苷对重症急性胰腺炎大鼠肠道损伤的保护作用及对肠组织p38MAPK/NF-κB表达的影响[J]. 新中医, 2021, 53(7):6-10. DOI: 10.13457/j.cnki.jncm.2021.07.002 .
	JIN L L, TANG B B, ZHOU J J, et al. Total saponins of Astragalus has protective effect on intestinal injury in rats with severe acute pancreatitis and its effect on P38MAPK/NF-κB expressions in intestinal tissues[J]. J New Chin Med, 2021, 53(7):6-10. DOI: 10.13457/j.cnki.jncm.2021.07.002 .
[27]	王欣, 周文勇, 孙月. 黄芪总皂苷通过激活Nrf2/HO-1信号通路缓解L-精氨酸诱导的小鼠急性胰腺炎氧化损伤的研究[J]. 现代中药研究与实践, 2022, 36(3):38-42. DOI: 10.13728/j.1673-6427.2022.03.008 .
	WANG X, ZHOU W Y, SUN Y. Study on the effect of Astragalus saponins on oxidative damage of L-arginine induced acute pancreatitis in mice by activating Nrf2/HO-1 signaling pathway[J]. Res Pract Chin Med, 2022, 36(3):38-42. DOI: 10.13728/j.1673-6427.2022.03.008 .
[28]	洪春霞, 张照伟, 陈伟前. 黄芪注射液通过调控mTOR/p70S6K信号通路对急性出血坏死型胰腺炎肺损伤炎症反应的影响[J]. 世界华人消化杂志, 2023, 31(5): 184-192. DOI: 10.11569/wcjd.v31.i5.184 .
	HONG C X, ZHANG Z W, CHEN W Q. Astragalus injection improves inflammatory response in lung injury in acute hemorrhagic necrotizing pancreatitis by regulating the mTOR/p70S6K signal pathway[J]. World Chin J Digestol, 2023, 31(5): 184-192. DOI: 10.11569/wcjd.v31.i5.184 .
[29]	李振国, 孔德生, 李文科. 黄芪多糖对大鼠急性胰腺炎的作用及其机制研究[J]. 海南医学, 2024, 35(1):6-9. DOI: 10.3969/j.issn.1003-6350.2024.01.002 .
	LI Z G, KONG D S, LI W K. Effect of Astragalus polysac-charides on acute pancreatitis in rats and its mechanism[J]. Hainan Med J, 2024, 35(1):6-9. DOI: 10.3969/j.issn.1003-6350.2024.01.002 .
[30]	HOU X T, YU M, XU Y, et al. Antioxidative effect of astragalosides on acute pancreatitis in mice[J]. Front Vet Sci, 2024, 11:1418899. DOI:10.3389/fvets.2024.1418899 .
[31]	PEERY A F, CROCKETT S D, MURPHY C C, et al. Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018. Gastroenterology. 2019, 156(1):254-272.e11. DOI: 10.1053/j.gastro.2018.08.063 .
[32]	尉洪利, 单连美, 孙玉欣, 等. 柴胡龙骨牡蛎汤对肝胆湿热证急性胰腺炎患者的临床疗效[J]. 中成药, 2025, 47(1):338-341. DOI: 10.3969/j.issn.100-1528.2025.01.056 .
	YU H L, SHAN L M, SUN Y X, et al. Clinical effect of Chaihu Longgu Muli decoction on acute pancreatitis with hepatobiliary damp-heat syndrome[J]. Chin Tradit Pat Med, 2025, 47(1):338-341. DOI: 10.3969/j.issn.100-1528.2025.01.056 .
[33]	林杉, 秦文昊, 代崧霖, 等. 中药辅助治疗经内镜逆行胰胆管造影术后急性胰腺炎研究进展[J]. 中国中西医结合杂志, 2024, 44(11):1400-1404. DOI: 10.7661/j.cjim.20240910.272 .
	LIN S, QIN W H, DAI S L, et al. Research progress on traditional Chinese medicine assisted treatment of acute pancreatitis after endoscopic retrograde cholangiopan-creatography[J]. Chin J Integr Tradit West Med, 2024, 44(11):1400-1404. DOI: 10.7661/j.cjim.20240910.272 .
[34]	谢红英, 罗晓丽, 卢慧. 黄芪注射液对病毒性心肌炎患者外周血NLRP3炎性小体表达的影响[J]. 西部中医药, 2021, 34(7):94-97. DOI: 10.12174/j.issn.2096-9600.2021.07.24 .
	XIE H Y, LUO X L, LU H. Influence of Huangqi injection on the expressions of NLRP3 inflammasome in peripheral blood of patients with viral myocarditis[J]. West J Tradit Chin Med, 2021, 34(7):94-97. DOI: 10.12174/j.issn.2096-9600.2021.07.24 .
[35]	张燕. 黄芪注射液联合布地奈德对支气管哮喘急性发作患者肺功能的影响[J]. 实用中西医结合临床, 2021, 21(17):71-72. DOI: 10.13638/j.issn.1671-4040.2021.17.033 .
	ZHANG Y. Effect of Astragalus injection combined with budesonide on lung function in patients with acute attack of bronchial asthma[J]. Pract Clin J Integr Tradit Chin West Med, 2021, 21(17):71-72. DOI: 10.13638/j.issn.1671-4040.2021.17.033 .
[36]	中华医学会外科学分会胰腺外科学组. 中国急性胰腺炎诊治指南(2021)[J]. 浙江实用医学, 2021, 26(6):511-519, 535. DOI: 10.16794/j.cnki.cn33-1207/r.2021.06.003 .
	Study Group Of Pancreatic Surgery In China Society Of Surgery Of Chinese Medical Association. Guidelines for diagnosis and treatment of acute pancreatitis in China(2021)[J]. Zhejiang Pract Med, 2021, 26(6):511-519, 535. DOI: 10.16794/j.cnki.cn33-1207/r.2021.06.003 .
[37]	LEPPÄNIEMI A, TOLONEN M, TARASCONI A, et al. 2019 WSES guidelines for the management of severe acute pancreatitis[J]. World J Emerg Surg, 2019, 14:27. DOI:10.1186/s13017-019-0247-0 .
[38]	宋艳, 何永恒, 杨芳, 等. 黄芪多糖调节脂联素/TLR/NF-κB信号通路对溃疡性结肠炎小鼠的治疗作用[J]. 中国免疫学杂志, 2021, 37(11):1319-1324. DOI: 10.3969/j.issn.1000-484X.2021.11.008 .
	SONG Y, HE Y H, YANG F, et al. Regulatory effect of Astragalus polysaccharide on adiponectin/TLR/NF-κB signal pathway in mice with ulcerative colitis[J]. Chin J Immunol, 2021, 37(11):1319-1324. DOI: 10.3969/j.issn.1000-484X.2021.11.008 .
[39]	HABTEZION A, GUKOVSKAYA A S, PANDOL S J. Acute pancreatitis: a multifaceted set of organelle and cellular interactions[J]. Gastroenterology, 2019, 156(7):1941-1950. DOI:10.1053/j.gastro.2018.11.082 .
[40]	LIU D L, WEN L L, WANG Z D, et al. The mechanism of lung and intestinal injury in acute pancreatitis: a review[J]. Front Med, 2022, 9:904078. DOI:10.3389/fmed.2022.904078 .
[41]	JIAO J Y, LIU J J, LUO F, et al. Qingyi granules ameliorate severe acute pancreatitis in rats by modulating the gut microbiota and serum metabolic aberrations[J]. Pharm Biol, 2023, 61(1):927-937. DOI:10.1080/13880209.2023.2222755 .
[42]	WANG L J, JIN Y L, PEI W L, et al. Amuc_1100 pretreatment alleviates acute pancreatitis in a mouse model through regulating gut microbiota and inhibiting inflammatory infiltration[J]. Acta Pharmacol Sin, 2024, 45(3):570-580. DOI:10.1038/s41401-023-01186-4 .
[43]	PALATHINGAL BAVA E, GEORGE J, TARIQUE M, et al. Pirfenidone increases IL-10 and improves acute pancreatitis in multiple clinically relevant murine models[J]. JCI Insight, 2022, 7(2): e141108. DOI:10.1172/jci.insight.141108 .
[44]	LI H Y, WU D, ZHANG H D, et al. Autophagy-mediated ferroptosis is involved in development of severe acute pancreatitis[J]. BMC Gastroenterol, 2024, 24(1):245. DOI:10.1186/s12876-024-03345-1 .
[45]	周龙云, 田子睿, 刘书芬, 等. 黄芪对中枢神经系统的药理作用及毒理研究现状[J]. 中草药, 2018, 49(20):4935-4944. DOI: 10.7501/j.issn.0253-2670.2018.20.034 .
	ZHOU L Y, TIAN Z R, LIU S F, et al. Review on neuroprotection effect of Astragali Radix on central nervous system and related toxicology[J]. Chin Tradit Herb Drugs, 2018, 49(20):4935-4944. DOI: 10.7501/j.issn.0253-2670.2018.20.034 .

黄芪或其成分治疗急性胰腺炎的动物实验Meta分析

Meta-Analysis of Animal Experiments on Astragali Radix or Its Ingredients for Acute Pancreatitis

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 7

参考文献 45

相关文章 15

编辑推荐

Metrics

本文评价

[1]	聂永强, 王朝霞. 高校基因编辑小鼠一站式服务平台建设的探索与实践：以上海交通大学为例[J]. 实验动物与比较医学, 2025, 45(5): 642-648.
[2]	高超奇, 祝志波, 孙显东. 大鼠血管重构模型的应用进展与分类分析[J]. 实验动物与比较医学, 2025, 45(5): 542-550.
[3]	王超, 李顺, 任晓楠, 杨华, 陈丽香, 徐春华, 周晓辉. 衰老抑制C57BL/6J小鼠肺部CD8⁺ T细胞对甲型H1N1流感病毒的记忆性免疫应答[J]. 实验动物与比较医学, 2025, 45(5): 515-523.
[4]	罗一凡, 张臻玮, 梅璐, 史叶萍, 邢艺彤, 张泽奇, 李楚欣, 韩春霞, 杨平顺, 陈秋生. 特络细胞介导肥胖症大鼠膏摩寡肽中草药复合制剂的减肥作用及其机制[J]. 实验动物与比较医学, 2025, 45(5): 551-560.
[5]	刘力瑜, 嵇波, 刘小玄, 方洋, 张玲, 郭亭廷, 全烨, 李鹤文, 刘翼天. 大鼠胎儿期肺组织固定方法的探索[J]. 实验动物与比较医学, 2025, 45(4): 432-438.
[6]	郑卿勇, 杨冬华, 马智超, 周姿余, 陆洋, 王晶宇, 邢丽娜, 康迎英, 杜莉, 赵春香, 狄宝山, 田金徽. 动物实验系统评价与Meta分析报告的规范撰写建议[J]. 实验动物与比较医学, 2025, 45(4): 496-507.
[7]	秦超, 李双星, 赵婷婷, 蒋晨晨, 赵晶, 杨艳伟, 林志, 王三龙, 文海若. 药物安全评价用SD大鼠90 d喂养试验的背景数据研究[J]. 实验动物与比较医学, 2025, 45(4): 439-448.
[8]	贡磊磊, 王晓霞, 封学伟, 李心蕾, 赵涵, 张雪艳, 冯欣. 不同浓度环磷酰胺诱导早发性卵巢功能不全小鼠模型及作用机制研究[J]. 实验动物与比较医学, 2025, 45(4): 403-410.
[9]	姜娟, 宋宁, 连文博, 邵丛丛, 顾文文, 石燕. 两种浓度乙醇溶液灌注建立小鼠宫腔粘连模型的组织病理和分子病理表型比较[J]. 实验动物与比较医学, 2025, 45(4): 393-402.
[10]	刘月琴, 薛卫国, 王淑友, 申耀华, 贾术永, 王广军, 宋晓晶. 探头式激光共聚焦成像技术用于小鼠消化道组织形态特征分析[J]. 实验动物与比较医学, 2025, 45(4): 457-465.
[11]	肖林林, 杨逸萱, 黎珊杉, 罗兰诗雨, 尹思威, 孙俊铭, 施维, 欧阳轶强, 李习艺. 利用脑立体定位技术将人源三突变APP基因导入海马区构建阿尔茨海默病大鼠模型[J]. 实验动物与比较医学, 2025, 45(3): 269-278.
[12]	罗莲莲, 袁艳春, 王俊岭, 时广森. 肌萎缩侧索硬化症小鼠模型研究进展[J]. 实验动物与比较医学, 2025, 45(3): 290-299.
[13]	姜萌, 郝淑兰, 仝立国, 仲启明, 高振飞, 王永辉, 王晞星, 吉海杰. 长春瑞滨诱导大鼠足背静脉炎模型的动态评价[J]. 实验动物与比较医学, 2025, 45(3): 251-258.
[14]	孔志豪, 魏晓锋, 于灵芝, 冯丽萍, 朱琦, 施国君, 王晨. 鳞状皮屑裸小鼠木糖葡萄球菌的分离鉴定[J]. 实验动物与比较医学, 2025, 45(3): 368-375.
[15]	潘颐聪, 蒋汶洪, 胡明, 覃晓. 慢性肾脏病大鼠主动脉钙化模型的术式优化及效果评价[J]. 实验动物与比较医学, 2025, 45(3): 279-289.